Skip to main content

Table 2 Comparison of clinical and laboratory variables of amayloidosis.

From: Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics

  Monsoury et al8 (with ASFA) Wakhlu et al 9 (with ASFA) Gomez-Casanovas et al7 (with SFA) Alishiri et al (with ASFB)
No. of patients 112 113 313 220
Positive for amyloid no (%) 8(7) 30(26.5) 51(16%) 15(6.8)
Subclinical amyloid (%) 62.5 73.3 67 46.6
Fat deposit analysis no 8 30 51 15
   1+ 7 23 12 13
   2+ 1 5 19 2
   3+ 0 2 20 0
Duration of disease (year) >5 >5 >5 >5
Age, yrs, mean ± SD 54(41–65) 46 ± 8.7 61.4 ± 13.7 55.2 ± 12
Male: female 0:8 8:22 1:19 1:3
Disease duration, years mean ± SD 17(12–25) 10 ± (5–22) 16.8 ± 10.5 9.13 ± 4.67(5–20)
Age at disease onset, years ± SD 32.5 (22–50) 36 ± 10 44.9 ± 14.4 46.07 (27–65)
Follow up. Mo, mean ± SD - 48 ± 36(12–14) 69.7 ± 53.3 12
RF positive, no. (%) - 25(83.3) 45(75) 10(66.6)
Proteinuria, no (%) 2(25) 7(23.3) 8(13) 8(53.3)
  1. ASFA: Abdominal Subcutaneous Fat Aspiration;
  2. ASFB: Abdominal Subcutaneous Fat Biopsy;
  3. RF: Rheumatoid Factor.